SLC5A2 and type 2 diabetes mellitus: A target trial emulation using Medicare data investigated the risk of suicidal ideation and behaviors in older adults with type 2 diabetes associated with GLP-1 RA compared to SGLT2 inhibitors and DPP-4 inhibitors.